Mammalian T cells of diverse functional types share a complex developmental history. They originate from pluripotent precursors in the bone marrow or fetal liver, which migrate to the thymus, the sole function of which is to initiate and sustain T-cell differentiation. Relatively few T-cell progenitors migrate into the thymus per day, but they respond to this new environment by proliferating extensively, while initiating the T-cell differentiation transcriptional programme [1] [2] [3] [4] and gradually turning off genes that allow differentiation to non-T-cell lineages. They then undergo T-cell receptor (TCR) gene rearrangements and assemble TCR complexes, upon which their future survival and functions will depend. These cells can mature into different T-cell lineages, including γδ T cells and αβ T cells. The αβ T cells further diverge into different sub-lineages, such as CD4 + T cells, CD8 + T cells, natural killer T (NKT) cells and regulatory T cells (T Reg cells), each of which have greatly differing functions once they emigrate from the thymus to the periphery. However, these diverse T-cell lineages share their early developmental history, and many of the key genes that are required in later T-cell functions are first expressed before TCR rearrangement. As the regulatory mechanisms that guide stem cells into the T-cell lineage become increasingly well defined, a sequence of events is being revealed that might make early T-cell development a particularly illuminating paradigm for stem-cell-based modes of development in general.
The T-cell-lineage commitment process consists of an irreversible progression of distinct developmental stages. Each of these stages has the potential to be sustained over multiple cell cycles. This implies that particular regulatory changes, perhaps environmentally triggered, must intervene to advance the cells from one stage to the next. Clear changes in gene expression and developmental potential mark these transitions. Yet genetic evidence, from germline and conditional knockouts, emphasizes the requirements for a stable core group of transcription factors that act repeatedly at successive stages. In this Review, we explore how this image of regulatory persistence can be modified to explain an outcome of dramatic and irreversible developmental change.
Landmarks for early T-cell development
We first review what happens in T-cell specification, before considering why it happens. From fetal through adult life, T-cell precursors develop through distinct stages defined by multiparameter flow cytometry 1, [5] [6] [7] [8] . In mice, cell-transfer experiments in vivo, as well as clonal-cell-culture experiments in vitro, have revealed at which stages these cells lose the non-T-cell-lineage developmental potential inherited from their stem-cell progenitors and when they gain specific T-cell-lineage characteristics [9] [10] [11] [12] [13] . The exact types of precursor cells that can participate, the branch points, the alternative pathways, and the kinetics of T-cell development are increasingly well defined in mice 1, 8, 9, 14, 15 and humans 7, 16 . This evidence, spanning contributions of many groups
NKT cells
A heterogeneous subset of natural-killer αβ T cells characterized by their expression of semi-invariant T-cell receptor α-chains together with NK-cell markers, and which are positively selected by interaction with non-classical MHC class I molecules. They perform regulatory and effector functions at the interface of innate and adaptive immune responses.
Regulatory T cells (T Reg cells)
. A rare population of CD4 + T cells that naturally express high levels of CD25 and the transcription factor forkhead box P3 (FOXP3), and that have suppressive regulatory activity towards effector T cells and other immune cells in the periphery. Many of them are thought to be generated by a special intrathymic alternative to negative selection.
KIT
A receptor protein tyrosine kinase, expressed by melanocytes, germ cells, stem cells and most immature haematopoietic cells. KIT binds the growth factor stem-cell factor (SCF), also known as KIT ligand or Steel factor.
for at least two decades, is summarized for the mouse case in BOX 1, FIG. 1 and TABLE 1.
Curiously, several distinct progenitor types can enter the T-cell pathway 9, 15 . But one major progenitor source in adult mice consists of lymphoid primed multipotent progenitors (lMPPs) in the bone marrow or blood, which can give rise to macrophages, dendritic cells (DCs), nK cells, B cells and T cells, but not erythrocytes or megakaryocytes 17, 18 . The earliest human thymic precursors also have lymphoid and myeloid potential 19, 20 . Within the mouse lMPP population, cells with the capacity to migrate to the thymus are probably distinguished by their expression of the CC-chemokine receptor 9 (CCR9), in addition to the stem-and progenitor-cell markers KIT (also known as CD117), stem-cell antigen 1 (sCA1) and the growth-factor-receptor tyrosine kinase FlT3 (FMsrelated tyrosine kinase 3; also known as FlK2) 9, 21, 22 . Pre-thymic cells in the fetal blood and liver might have somewhat different properties from postnatal thymusseeding cells 23, 24 . Development through the first 'pro-T-cell' stages -that is, from the early T-cell-lineage progenitor (ETP) stage to the double-negative 3 (Dn3) stage -is independent of the TCR and is coordinated with migration through distinct thymic microenvironments 8 (FIG. 1) . ETPs and Dn2 cells proliferate extensively while acquiring their first T-cell characteristics. Although precursors may actually initiate TCR (or immunoglobulin heavy chain) gene rearrangements abortively, some even before reaching the thymus 25, 26 , none of these have the full v(D)j rearrangement required to permit expression of the genes encoding TCRβ, TCRγ and/or TCRδ. As the T cells reach the Dn3 stage, they stop proliferating, greatly increase TCR gene rearrangement and generate the first fully rearranged TCR loci. Dn3 T cells that succeed in making in-frame TCR gene rearrangements become activated by TCR-dependent selection (these are referred to as Dn3b cells); this distinguishes them from Dn3 cells that are not yet selected (referred to as Dn3a cells) 27 . Expression of TCRβ qualifies the cells to undergo β-selection, turning on expression of CD4 and CD8 to become double positive (DP) cells, and eventually acquiring cell-surface TCRαβ complexes. This prepares them for positive selection and negative selection to generate mature CD4 + or CD8 + TCRαβ + T cells. Alternatively, Dn3 T cells that successfully rearrange TCR γ-and δ-chains instead of β-chains are selected as γδ T cells.
The thymic epithelium provides a particularly potent combination of receptor ligands and growth factors to trigger and support pro-T-cell differentiation, proliferation and survival 8, 11, 15, 28 . The most important of the environmental inputs for T-cell development are ligands for the Notch cell-surface receptors, specifically delta-like ligand 1 (Dll1) and Dll4 (REF. 29 ). notch signalling initiates and sustains the T-cell-lineage programme throughout the pro-T-cell stages, and presentation of notch ligands by stromal cells is the key element in successful tissue culture systems that support early T-cell development in vitro 30 . In addition, the thymic epithelium produces ligands for other signalling pathways and cytokines, such as the KIT ligand stem-cell factor (sCF) and interleukin-7 (Il-7), both of which are critical for sustaining the proliferation that pro-T cells undergo at defined stages. Migration of the pro-T cells through different zones of the thymus might provide changing microenvironmental signals that help to drive T-cell differentiation programming 8 . Furthermore, more mature thymic T cells can themselves have direct or indirect feedback effects on the gene expression and differentiation of early T cells 2, 31 .
Stages in programming for T-cell identity
Programming for T-cell-lineage identity includes both specification, which confers T-cell-specific functions and commitment, or loss of the ability to adopt alternative developmental fates.
The cells gain their T-cell characteristics by a multistep cascade rather than co-ordinately. FIG. 2a depicts these gene expression changes on a colour-coded logarithmic scale (>5,000-fold range), because although relatively modest changes in gene expression can be functional, the T-cell specification process also includes changes of much greater magnitude. T-cell identity genes, as well as the transcription factors that regulate their expression, are turned on in a precise order. The T-cell identity genes encode products that are critical for TCR rearrangement (such as recombination activating gene 1 (RAG1) and RAG2), TCR complex assembly (such as the CD3 chains) and signalling components, including kinases, phosphatases and adaptor proteins such as lCK, ZAP70 (ζ-chain-associated protein kinase of 70 kDa), and lAT (linker of activated T cells). There is little activation of these genes in cell precursors before they enter the thymus (although there are some possible exceptions 26, 32 ) and, within the thymus, ETPs express relatively few T-cell identity genes, mostly at low levels. Most of these genes begin to be upregulated
Box 1 | Purification of early thymic subsets
A high level of cell-subset purity is particularly important to allow gene expression to be analysed reproducibly and for the results to be correlated meaningfully with developmental assays. Although the CD4 -
CD8
-double negative (DN) early T-cell subsets are usefully subdivided by their expression of CD25 and CD44, those parameters alone are insufficient for rigorous purification of DN subsets without contaminating cells 6 . In particular, the CD25 -
CD44
+ so-called DN1 population is very heterogeneous and only a minority of thymocytes with this phenotype are actually early T-cell precursors 25, 131 . In addition to unrelated haematopoietic cells, this population is often contaminated with mature natural killer (NK) cells, NKT cells and γδ T cells. Such cells often share high levels of CD44 expression with genuine T-cell precursors, and even when depletion protocols are designed to remove cells expressing the T-cell receptor (TCR) and NK-cell markers as well as cells expressing CD4 and CD8, the low levels of expression of mature cell-surface receptors on these cell types cause inefficient depletion. Additional use of selection protocols based on surface expression of KIT allow for more efficient purification of the potent Tcell-lineage precursors 6, 25, 131 , and in this Review we use the term ETP (early T-cell precursor) 25 to refer to the KIT ++ DN1 cells (FIGS 1,3) . Likewise, evidence is accumulating that DN2 cells are not a homogenous population. They can be subdivided, based on their cell-surface expression levels of KIT, into DN2a and DN2b populations (FIG. 3) , and recent data show that this distinction may correspond to the loss of dendritic-cell potential 33 . DN3 cells can also be subdivided into those before and immediately after β-or γδ-selection (DN3a and DN3b, respectively) based on size 132 and CD27 expression 27 . These finer distinctions between sequential developmental stages give a sharper resolution to the changing gene regulatory events that take place during the course of T-cell differentiation. 27, [33] [34] [35] [36] [37] [38] . Finally, by the Dn3a stage of T-cell development, T-cell-lineage identity is set. Germline transcription of the variable-region gene segments encoding TCRβ is also upregulated 39 as v(D)j rearrangement of genes encoding TCRβ proceeds 27 . Even effector genes such as Il2 become accessible for induction 40 . The cells are still far from mature T cells, but they have completed assembly of the whole TCR signalling apparatus that is necessary for β-or γδ-selection, as well as for positive and negative selection and mature cell functions thereafter.
Concurrently, there are staged shifts in growth factor receptor expression (FIG. 2a) . KIT expression is essential in the earliest precursors 41 , then is gradually downregulated through the Dn3 stage 37 , whereas Il-7Rα, which sustains most pro-T-cell proliferation 42 , is strongly expressed in Dn2 and Dn3 stages until after β-selection. Meanwhile, Il-2Rβ, an important growth factor receptor for nK cells and mature T cells, is downregulated in a mirror opposite pattern to Il-7Rα (FIG. 2a) . This downregulation is functionally significant because Il-2Rβ, although related to Il-7Rα, transmits different signals that can divert immature thymocytes from the T-cell lineage to the myeloid lineage 43 . Commitment also occurs in discrete steps. In adult mice, whereas some thymus-seeding progenitors initially retain B-cell-lineage developmental potential, they all rapidly lose this capability once inside the thymus, as FlT3 and CCR9 are downregulated 44, 45 . T-cell precursors that populate the fetal thymus appear to have lost B-cell potential before entering the thymus 11, 12 . nevertheless, both adult and fetal thymic immigrants retain the potential to develop into DCs or nK cells until a later stage 36, [46] [47] [48] [49] , and at least some also have the potential to develop into macrophages and/or mast cells 36, 50 (FIG. 1) .
Both ETPs and many Dn2 cells show readily detectable potential to develop into DCs and nK cells if they are removed from the thymus and cultured in permissive conditions. However, by the time the cells reach the Dn3 stage, they are committed to the T-cell lineage and can no longer develop into alternative cell types under any of these conditions (reviewed in REF. 51 ).
Individual ETPs can embark on these alternative pathways somewhat more easily than Dn2 cells can 47, 52 . until recently, the graded reduction in DC and nK-cell developmental potential at the Dn2 stage could be interpreted stochastically, with Dn2 cells simply becoming less likely to access their non-T-cell options than ETPs. However, recent evidence 33 shows a discrete transition in the midst of the Dn2 stage, while the cells are still proliferating and before extensive TCRβ rearrangement. Activation of a green fluorescent protein transgene driven by the proximal Lck promoter proves to distinguish late from early Dn2 cells. At this point, cells specifically lose the ability to adopt the DC fate 33 (FIG. 1) . This transition seems likely to be correlated with the first slight reduction in expression of KIT by non-transgenic Dn2 cells that we refer to as the transition from the Dn2a stage to the Dn2b stage 6 (FIG. 3) . The discovery of this transition 33 shows that the potential to develop into at least three different T-cell-lineage alternatives -B-cells, DCs and nK cells -may each be relinquished at successive stages. Commitment is not a single event, but a cascade of separate developmental renunciations that only ends at the Dn3 stage when all non-T-cell options have been lost. loss of the potential to develop into DCs appears to be coupled with a discrete regulatory event that unleashes the full T-cell differentiation programme 33 , a coupling much tighter than was previously evident. only a few of the T-cell-identity genes are upregulated by the Dn2a stage (FIG. 2c) . The earliest-responding genes are not differentiation genes but encode the transcription factors HEBalt (Hela E-box binding factor, alternative form) and BCl-11b (B-cell lymphoma 11b) 53 , discussed below. some genes that have key roles in β-selection (such as Ptcra (pre-TCR α-chain) and Rag1) are strongly upregulated only at the Dn2b stage or at the Dn2b to Dn3a stage transition 27,32,34,36,37 (FIG. 2c) . The question is . ETPs, DN2, DN3 and DN4 T-cell subsets are defined as described in TABLE 1 . Note that at any given stage of the cell cycle, the ETPs appear to have the options either to continue their expansion with minimal differentiation in the cortico-medullary junction region or to differentiate into DN2 cells (presumably DN2a cells as shown) that can begin their migration from the site of entry deep within the cortex to the outer rim of the cortex. β-selection occurs during the accumulation of the DN3 T cells in the extreme outer portion of the thymus (that is, the subcapsular zone). A directional reversal of migration back across the cortex towards the medulla occurs for the later stages of thymocyte development. Broken arrows depict alternative developmental pathways that are still possible for ETPs and for different subsets of DN2 cells that are likely to correspond to DN2a and DN2b cells before they complete their commitment to the T-cell-lineage. CCR9, CC-chemokine receptor 9; ISP, immature single positive; LMPP, lymphoid primed multipotent progenitor; NK, natural killer; TCR, T-cell receptor. 
Negative selection
The intrathymic elimination of double-positive or singlepositive thymocytes that express T-cell receptors with high affinity for self antigens.
Notch
A transmembrane receptor involved in the pathway for direct cell-cell signalling through its association with a transmembrane ligand of the delta or serrate/jagged family on a neighbouring cell. The large intracellular domain of Notch is cleaved and travels to the nucleus to become a direct co-activator of the transcription factor RBPJ (CSL).
Interleukin-7
(IL-7). The major growth factor for immature T and B cells and for homeostatic proliferation of post-thymic naive T cells. It triggers a heterodimeric receptor composed of the IL-7 receptor α-chain (also known as CD127) coupled with the common γ chain (also known as CD132).
therefore what changes in transcription factor and signalling activities (jointly termed T-cell-lineage regulatory factors) can explain these abrupt changes in gene expression and behaviour.
T-cell-lineage regulatory factors: core group As shown in FIG. 2b,c there are indeed major changes in transcription factor expression during the progression of T-cell precursors from the ETP to the Dn3 stage. This is evident for the specific transcription factors that we have chosen to show in FIG. 2b, which include most of the T-cell factors known to be essential for early T-cell development (as indicated by the stars in FIG. 2) , as well as most factors implicated in cell-lineage plasticity, those implicated in the regulation of TCR and other T-cell-lineage gene expression, and their closest relatives.
notch signalling is the best-studied T-cell-lineage positive regulator. on activation, the notch intracellular domain (notchIC) converts the transcription factor RBPj (recombination site binding protein j; also known as Csl) from a default repressor to an activator (reviewed in REFS 29, 54) . several T-cell-lineage genes are directly activated by the notch-RBPj complex, including distinguishing markers for the Dn2 and Dn3 stages such as Ptcra and the Dn2-Dn3-stage-specific marker Cd25 . Another direct notch target gene encodes the transcription factor HEs1 (hairy, enhancer of split 1). notchIC is the only regulator known to be able to drive ectopic T-cell development when overexpressed. However, notch signalling alone is not sufficient to activate or sustain the T-cell developmental programme.
Genetic evidence emphasizes the roles of a core group of diverse transcription factors or transcription factor families that must work with notch in the T-cell specification process, either during or before the intrathymic T-cell precursor stages 2,58-60 (TABLE 2) . This core group of factors includes: GATA3 (GATA-binding protein 3) 61 ; MYB; RunX1-CBFβ (runt-related transcription factor 1-core binding factor β) complexes; basic helix-loop-helix E proteins 62 such as E2A (encoded by Tcfe2a and HEB (encoded by Tcf12); high-mobility group factor TCF1 (T-cell factor 1; encoded by Tcf7); the zinc-finger repressor GFI1 (growth factor independent 1 transcription repressor); and Ikaros family members (FIG. 2;  TABLE2 ). These factors are discussed extensively in the following sections, as their roles are not only essential but are also recurrent in T-cell development. Most of these have expression patterns consistent with persistent roles throughout the ETP to Dn3 stages (FIG. 2) : they are already expressed at relatively high levels by ETPs and are upregulated only modestly compared to many other pro-T cell genes. However, the continuous expression of these core genes cannot explain the discontinuities in gene expression observed during T-cell differentiation.
Stage-specific T-cell transcription factors T-cell development also depends on factors that do not have sustained roles. of these, the best studied is the ETs (E26-transformation specific) family factor Pu.1 (encoded by Sfpi1) (FIG. 2) . Pu.1 is another 'core-group' member, but with a difference: whereas it is vital for prethymic precursor development, once the cells progress to the Dn2a and Dn2b stages Pu.1 switches its function to that of a T-cell-lineage antagonist and must then be silenced. As described below, Pu.1 belongs to a cohort of pre-thymically inherited factors, including sCl (stem-cell leukaemia; also known as TAl1), GATA2
and C/EBPα (CCAAT-enhancer binding protein α) (FIG. 2) , that most likely sustain the lineage plasticity of cells in early stages of T-cell development. All of these factors are downregulated to essentially undetectable levels before β-or γδ-selection (FIG. 2b,c) , and the downregulation of these non-T-cell factors is strongly correlated with the activation of the T-cell gene expression programme.
not all transcription factors inherited from haematopoietic stem cells are turned off during T-cell specification. Many of the core-group factors also have important pre-thymic roles. There is also a large set of transcription-factor genes that continue to be expressed stably from multipotent progenitor stages all the way to cell stages undergoing β-selection 53 . But only a few transcription-factor genes are specifically turned on at a time that might contribute to the onset of T-cell-lineage gene expression in the Dn2 stage. These include the zinc-finger transcription factor and tumour suppressor factor BCl-11b 63 , HEBalt 53, 64 and, more transiently, GlI2 (glioma-associated oncogene 2) a transcription factor involved in the hedgehog signalling pathway 65 . To explain the further increase in T-cell gene expression at the Dn3 stage, several additional factors that have been implicated through direct studies of the regulatory elements of TCR and other T-cell genes (reviewed in REF 2) need to be considered. ETs-family and zincfinger factors are prominent, specially ETs1, which works in an intimate collaboration with RunX1-CBFβ (REFS. 66, 67) . Both of the genes encoding ETs1 and ETs2 are included in a group of transcription-factor genes, which includes the T-cell factor 1 (TCF1) relative lEF1 (lymphoid-enhancer-binding factor 1), that are strongly upregulated at the Dn2 to Dn3 stage transition 34 (FIG. 2b) . The Dn3 stage is also distinguished by peak levels of expression of the Pu.1-related factor sPIB and 
HEBalt
An alternative short form of the transcription factor HEB (HeLa E-box-binding protein; also known as TCF12), which has the same DNA binding and dimerization domains as the canonical form of HEB but which has an alternative N-terminus and distinct functionality.
Hedgehog signalling pathway
A signalling pathway that promotes growth or differentiation during embryonic development and T-cell development. Hedgehog family soluble ligands activate transcription factors of the GLI (glioma-associated oncogene) family through a complex pathway involving two transmembrane receptors, Patched and Smoothened, and a double inhibition system.
of HEs1, a target of the notch-RBPj complex, which are turned off after β-selection. An additional highmobility group factor, soX13, has recently been shown to have a specific, essential role for the generation of γδ T cells 68 ; however, soX13 is expressed throughout the pro-T-cell stages, and is only downregulated in cells that express the TCRβ.
Therefore, although notch signalling occurs throughout all stages, the transcription factor expression profile of the cells progressing from the ETP to Dn3 stages consists of several distinct layers. on a background of expression of factors that are inherited from pre-thymic progenitor cells 53 there is maintenance of, or a gradual increase in, the expression of the core-group All measurements were carried out as previously described 27, 34, 35, 38, 50, 52, 53, 68, 96 , and similar results are reported by others 33, 36, 37, 133 . The amounts of mRNA expressed are normalized to β-actin at each developmental stage and the values depicted as heat maps, using a colour code to indicate relative levels on a logarithmic scale as previously described 53 . Although small differences in gene expression levels can be meaningful, this method provides the dynamic range to depict changes of both smaller and larger magnitude. Briefly, the central value (mid) for each gene is the geometric mean of the maximum and minimum expression levels for that gene in the sample series, and the threefold range around this value is coded green. In a and b, the mid value shown is for all cell subsets; in c the mid value shown is only for ETP, DN2a, DN2b and DN3 cells. The overall range of expression is then separated into discontinuous 'bins' in which each shade redder represents a threefold increase in mRNA, whereas each shade bluer represents a threefold decrease. This analysis permits comparison between patterns of expression but does not indicate absolute RNA accumulations: poorly expressed genes can give variability in the lower range as the central value itself is close to the detection threshold. Red stars indicate essential members of the regulatory core group. Orange stars indicate partially redundant members of the core group. Blue stars mark PU.1 (also known as Sfpi1), an early core group member that later switches to become an antagonist of T-cell development. Bcl, B-cell lymphoma; Dtx1, deltex homologue 1; Gfi1, growth-factor independent 1; HEBalt, HeLa E-box-binding protein, alternative form; HEBcan, HeLa E-box-binding protein, canonical form; Hes1, hairy, enhancer of split 1; Id, inhibitor of DNA binding; Il2rb, interleukin-2 receptor β-chain; Il7ra, interleukin-7 receptor α-chain; Lat, linker for activation of T cells; Lef1, lymphoid-enhancer-binding factor 1; Ptcra, pre-T-cell-receptor α-chain; Rag1, recombination-activating gene 1; Runx, runt-related transcription factor; Scl, stem-cell leukaemia; Sox13, SRY box 13; Tcf7, T-cell factor 7; Tcr, T-cell receptor; Zap70, ζ-chain-associated protein kinase of 70 kDa. Nature Reviews | Immunology Competence to turn on the T-cell programme notch signalling is vital to initiate T-cell development, but it is not sufficient to activate T-cell-lineage genes directly + Dn2 cells, and ultimately DP cells, can be generated from various types of haematopoietic precursors through a reproducible molecular pathway 35, 53, 70, 71, 73 . Although notch signalling turns on tissue-nonspecific genes such as Hes1 and Nrarp (notch-regulated ankyrin-repeat protein) in many cells within the population, expression of the key T-cell transcription factors GATA3 and TCF1 is only induced within a subset of these precursors. A smaller subset of these then proceeds to a Dn2-like state, turning on the expression of genes that encode CD25, Thy1, CD3ε, pTCRα and BCl-11b 35, 53 . Because only select types of haematopoietic precursor activate these T-cell genes in response to notch, it is clear that additional factors are needed 35 . At least four transcription factor contributions now appear to be required to enable cell progenitors to undergo the T-cell-lineage initiation response: Pu.1 (REFS 75, 76) ; and E protein activity from E2A and possibly its homologues such as HEB. Haematopoietic precursors already express E proteins, but in these cells they are engaged, to unknown extents, in complexes with inhibitor of DnA binding (ID) proteins or sCl, and this does not allow them to activate T-cell-lineage specific genes. In a multipotent haematopoietic progenitor cell line, E2A levels positively regulate some notch target and T-cell-lineage genes including Notch1 itself, with synergistic effects of E2A and notch signalling 78 . This is the first of multiple stages at which E proteins and notch work together in early T-cell development (FIG. 4) .
The competence of haematopoietic precursors to respond to notch signals and thereby follow the T-cell-lineage developmental programme is under negative as well as positive regulation. one newly defined mechanism is mediated by the transcriptional repressor lRF (leukaemia/lymphoma related factor; also known as Zbtb7a or Pokemon). lRF makes B-cell development possible by counteracting notch responsiveness in pre-thymic haematopoietic precursors 79 . It limits expression of Notch1 and Notch3, and, either by direct repression or as a result of reduced notch expression, it keeps T-cell-lineage genes silent. In the absence of lRF, T-cell specification genes are spontaneously activated in bone marrow progenitors 79 . Therefore, even before notch signalling, T-cell precursor competence is defined by expression of Pu.1, Ikaros, RunX1-CBFβ complexes and readily mobilized E proteins. In each subset, lRF may also be important for establishing the threshold that the notch signals must overcome to initiate the T-cell developmental programme in those cells.
ETP to DN2 stage: delay versus progression
ETPs are clearly excellent T-cell precursors, but they present some paradoxes. ETPs profoundly depend on notch-driven transcription for their maintenance 45, 80, 81 , and they already strongly express the notch-promoted genes Hes1, Gata3 and Tcf7 at levels well above those of pre-thymic progenitors 53, 80 . However, unlike cells that respond to notch in vitro, adult mouse ETPs delay their activation of Dn2-stage target genes by many days (~10 days) and many cell cycles 8 . Although some ETPs already have Djβ TCR gene rearrangements 25 , their expression of RAG recombinases is barely detectable (FIG. 2a,c) . The length of time that ETPs spend proliferating is also variable and subject to regulation: it is much shorter for fetal thymocytes, and the size of the ETP pool is adjusted dynamically on the basis of niche availability and homeostatic feedback 82, 83 . so, even when the requirements are met for initiating T-cell-lineage development in response to notch signals, which presumably include MYB, RunX1-CBFβ, Ikaros and E proteins, there must be additional regulatory inputs that control whether haematopoietic precursors stay in a 'holding pattern' for another cell cycle as ETPs or 'graduate' towards the Dn2 stage (FIG. 1; FIG. 4a ).
TCF1 and the transcriptional repressor GFI1 are two regulators that are specifically needed to generate Dn2 cells 84, 85 (FIG. 4b) . It is not clear yet whether GFI1 controls the transition from ETPs to Dn2 cells itself or helps to make competent ETPs, and there is little increase in the expression of GFI1 from ETPs to Dn2 cells (FIG. 2b) . TCF1 is an attractive candidate for a rate-limiting positive regulator of the transition to the Dn2 stage because of its increasing, notch-dependent expression pattern 34, 53 and because many T-cell-lineage differentiation genes, including Cd3g and Cd3e, have predicted TCF1 binding sites in their promoter regions (H. T. Petrie and M. Fallahi, personal communication). Analogous to the notch pathway, microenvironmental WNT signalling can convert TCF1 to an activator through interaction with β-catenin 86, 87 . However, . bHLH, basic helix-loop-helix transcription factor; CBFβ, core binding factor β; DC, dendritic cell; DN, double negative; ETS, E26-transformation specific; GATA3, GATA-binding protein 3; GFI1, growth factor independent 1 transcription repressor; HEBalt, HeLa E-box binding factor, alternative form; HEBcan, HeLa E-box binding factor, canonical form; HMG, high-mobilty group; LEF1, lymphoid-enhancer-binding factor 1; ND, not determined; RBPJ, recombination site binding protein J; RUNX1, runt-related transcription factor 1; SP, single positive; TCF1, T-cell factor 1; TCR, T-cell receptor; TIG, transcription factor immunoglobulin.
WNT
A signalling mediator named both for its mutant phenotype in Drosophila melanogaster (Wingless) and for its role as a preferential retrovirus integration site in murine leukaemia virus-induced leukaemias (Int-1). WNT signalling activates the TCF1 and LEF1 family transcription factors through stabilizing their co-activator, β-catenin, and mobilizing it from the cytoplasm to the nucleus.
indirect evidence suggests that WnT signalling may already be occurring in most ETPs 87, 88 . Additional regulatory inputs that delay ETPs from proceeding to the Dn2 stage must exist in the adult thymus, and notably, at least three microenvironmental signalling systems are implicated.
Progression of ETPs to the Dn2 stage can be held back by the action of certain members of the bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) families [89] [90] [91] , which appear to promote the self renewal of ETPs. The effects of these environmental signals seem to be counteracted by activation of the hedgehog signalling pathway, working through GlI2, which appears to enhance the generation of Dn2 cells 65 (FIG. 4a) .
notch itself may also have a two-sided role. MsX2-interacting protein (MInT) is a natural damper of notch-dependent transcription 92 and is normally expressed abundantly in ETPs, with levels declining as the cells develop into Dn3 cells and after β-selection. MInT-deficiency should therefore be expected to increase notch-mediated transcriptional activation, which in turn could enhance T-cell specification. However, the observed phenotype is the opposite: in MInT-deficient mice ETPs accumulate and there is a reduced transition to the Dn2 stage. Is too much notch signalling, therefore, a stalling factor that blocks T-cell development at the ETP stage? Crosstalk with Hedgehog, BMP or WnT pathway mediators could potentially underlie the defect, but this has not yet been tested. Another pathway may be through direct notch target gene nRARP, a cytoplasmic ankyrin-repeat protein that can act as a potent feedback inhibitor of notch signalling, targeting a different aspect of the notch signalling pathway than MInT 93 . When MInT is deleted, ETPs accumulate much higher levels of RnA encoding nRARP than normal ETPs, losing one kind of notch modulator but gaining another 92, 93 , and this could also bias MInT-deficient ETPs to expand without progressing. In either case, the role of MInT shows that a notch-dependent gene regulatory network, not simply notch signalling alone, may channel cells differentially between the self-renewal of ETPs and transit to the Dn2 cell stage.
Lineage plasticity of early T-cell precursors notch signalling has an important role in the 'negotiation' over cell fate throughout the ETP stage and into the Dn2 stage. Although all but the earliest CCR9 + FlT3 + immigrants have lost B-cell potential, at least some of these cells retain myeloid, DC, nK-cell and even (rarely) mast-cell 50 potential, as revealed under permissive environmental conditions. This lineage instability reflects the mixture of T-cell-lineage and persisting stem-cell transcription factors in ETPs and Dn2 cells (reviewed in REFS 51, 58, 94) (FIG. 2) . 'non-T-cell factors' present in ETPs and Dn2a cells, such as ID2, sCl, C/EBPα, GATA2 and Pu.1, are likely to have direct roles in maintaining non-T-cell developmental options. C/EBPα and Pu.1 are each sufficient to impose a myeloid or DC developmental programme on T-cell-lineage precursors if expressed ectopically after their endogenous expression is normally turned off 52, [95] [96] [97] , and Pu.1 is required for normal DC development from thymocytes 97 . ID2 and sCl work as modulators or antagonists of E-protein activity, and such antagonism is crucial for ID2 to promote nK-cell development 98, 99 . not only do these non-T-cell factors promote specific alternative pathways, but they also make the regulatory state of ETPs and Dn2 cells intrinsically unstable. In these stages, even GATA3, a transcription factor of the T-cell-lineage core group, can drive alternative fates, only supporting the early stages of T-cell development within a highly limited dose-response range 50 . Increased concentrations of GATA3 drive ETPs and Dn2 cells into the mast-cell lineage 50 , although GATA3 is clearly and repeatedly essential for T-cell development at multiple stages 59, 61 . Early T-cell precursors are also sensitive to cytokine stimulation of ectopic receptors, such as the GM-CsF (granulocyte/macrophage colony-stimulating factor) receptor or the Il-2Rβ-γ c complex: cytokine signalling of these receptors is sufficient to activate a myeloid developmental programme in ETPs or Dn2 cells 43, 100 . This can occur by triggering upregulation of C/EBPα and/or Pu.1 activity 101, 102 , or by precocious activation of protein kinase C or RAs, mediators normally activated by TCR signalling but which strongly enhance lineage diversion if Pu.1 is present 96 . The cells only stabilize their T-cell identity when these non-T-cell factors are finally silenced.
uncommitted precursors are probably restrained from these developmental alternatives in vivo by interaction with intrathymic notch ligands 19, 50, 52, 95 . notch signalling inhibits, although it does not eliminate, the potential to differentiate into nK cells 47, 103, 104 . Although notch signalling does not repress Pu.1 directly, it does protect newly induced T-cell-lineage differentiation and regulatory genes from repression in the presence of high concentrations of Pu.1 (REF. 52 ), thus tilting the balance of a bistable regulatory switch towards T-cell-lymphoid and against myeloid fate 58 . Through a different pathway, notch-Dll interactions also restrain GATA3-overexpressing cells from diversion to the mast-cell lineage 50 . The biochemical mechanisms remain to be determined, but in each case, notch Box 2 | Same transcription factor protein, different target-gene effects Several general principles make it possible for the same transcription factor protein to have effects on widely different sets of target genes at different stages in a developmental process. First, the effect of a particular transcriptional regulator depends on its dose, owing to DNA-binding biophysics. Transcription factors at high concentration can bind to a wider range of DNA sites than they can at low concentration. Second, the effect of any essential regulatory factor depends on combinatorial interaction with other factors and signalling pathways. These affect the binding of the essential factor to particular cis-regulatory elements, sometimes in an all-or-nothing fashion, and may change the net effect from activation to repression or vice versa. Finally, the effect also depends on the gene network within which the factor of interest operates. Among the target genes activated by a factor can be genes encoding inhibitors of the initial regulator itself. Such negative-feedback regulation can make a significant difference between the impact of a factor when continuously expressed and the impact of the same factor when activated in a discontinuous or oscillating manner. Therefore, it is likely to be significant that several Notch target genes expressed in pro-T cells encode inhibitors of Notch signalling itself 93, 133 . Nature Reviews | Immunology signalling acts to preserve access to the T-cell-lineage programme without extinguishing regulators for other developmental options.
RUNX1-CBFβ

PU.1 Tal1
Effects on E proteins may be at the crux of the balance between T-cell and non-T-cell developmental alternatives 58 for ETPs and Dn2 cells. Both the nK-cell pathway and the myeloid and DC alternatives to T-cell development involve repressing or neutralizing E proteins. When either Pu.1 or C/EBPα is re-introduced to committed Dn3 cells to divert them to a myeloid or DC fate, one of their earliest effects is to inhibit net E-protein activity 52, 95 . HEBalt is a particularly sensitive repression target 52, 96 . Correspondingly, notch signalling maintains HEBalt and inhibits upregulation of ID2 in response to Pu.1 (REF. 52 ). The different roles of various E protein heterodimers make them challenging to study, but these results suggest that E-protein activity might be pivotal for the lineage fidelity of early T-cell precursors. 2, 29, 54, [58] [59] [60] [61] [62] 77, 84, 85, [111] [112] [113] [114] [115] . Note the repeated inputs from Notch signalling and E proteins at successive stages, and the importance of MYB, RUNX1-CBFβ (runt related transcription factor 1-core binding factor β), and GATA3 (GATA-binding protein 3) both in the earliest stages and in the functions of double-negative 3 (DN3) cells. The DN2 substages (that is, DN2a and DN2b) are not shown, as no distinction had yet been made between these at the time at which the data shown in this figure were published. The factors promoting T-cell differentiation at a particular cell-stage transition and the factors promoting alternatives to T-cell development are indicated. a | Summary of the essential proteins required for the development from haematopoietic stem cell (HSC) to the early T-cell-lineage progenitor (ETP)-DN2-stage choice point. The stages at which cells become primed to respond to Notch signals by undergoing T-cell-lineage specification are shown. Evidence for a possible early role of E protein is noted but its timing is uncertain. The term precursor cell refers to any relevant pre-thymic precursor population (not specifically defined). Once the ETP stage is reached, ETPs can either undergo further self-renewal or proceed to the DN2 stage; both choices can enhance T-cell development although with different kinetics. b | Summary of the recursive roles of E proteins and Notch-DLL (delta-like ligand) signalling during the transition from the ETP stage through the β-selection checkpoint. The developmental alternatives that are still available at the DN2 stage, and the potential reversal of the DN2 to DN3 stage transition, are indicated by broken arrows. The β-selection checkpoint is shown at the boundary between T-cell receptor (TCR)-independent developmental stages on the left and the later TCR-dependent developmental stages in the shaded zone on the right. The later developmental changes from DN4 to ISP (immature single positive) to double positive (DP) stages are not shown as discrete transitions. The major increases or decreases in the expression of other transcription factor genes are indicated in the bottom part of the figure. BMP, bone morphogenetic protein; BCL-11b, B-cell lymphoma 11b; ETS, E26-transformation specific; GFI1, growth factor independent 1 transcription repressor; HEBalt, HeLa E-box binding factor, alternative form; Hes1, hairy, enhancer of split 1; ID, inhibitor of DNA binding; Lef1, lymphoid-enhancer-binding factor 1; LRF, leukaemia/lymphoma related factor; MINT, MSX2-interacting protein; SHH, sonic hedgehog; TCF1, T-cell factor 1.
HEBcan
Designation for the canonical form of HEB (HeLa E-boxbinding protein; also known as TCF12), as contrasted with HEBalt.
Why is broad lineage plasticity retained so long by early T-cell precursors? one possible answer is that until TCR gene rearrangement, pro-T cells regulate their proliferation through mechanisms shared with multipotent haematopoietic progenitors, and that the non-T-cell factors are part of this mechanism. ID2 is directly involved in cell-cycle progression in many cell types 105 , and it might be indispensable to maintain proliferation in the presence of high levels of E-protein activity until another, lymphoid-specific ID factor, ID3, becomes induced (FIG. 2) . Both Pu.1 and sCl are important for maintenance of multipotent haematopoietic progenitors 75, 76, 106, 107 , possibly through target genes such as Kit 108, 109 and the cell-cycle activator Cdk6 (REF. 110 ). Thus, throughout the pro-T cell stages, the T-cell-specific gene expression programme might gradually be assembled onto the 'armature' of a proliferating multipotent progenitor state. If so, this armature can apparently be removed only when assembly is complete.
T-cell-lineage commitment: transit to DN3 stage After the plasticity of the ETP and Dn2 stages, the Dn3 stage marks a break. not only do most T-cell genes become fully activated, but also, the cells lose all non-T-cell developmental options and stop proliferating. The transition from proliferative expansion to cell-cycle arrest enables the TCR gene rearrangement process to be fully activated. During in vitro differentiation, the Dn2 cell population often expands abnormally at the expense of the Dn3 cell generation, implying that this transition also requires specific regulation 72, 111 . A phenotypically normal Dn2 to Dn3 stage transition depends on RunX1-CBFβ complexes, and RunX1-CBFβ, MYB, GATA3 and BCl-11B are needed for full TCRβ gene rearrangement and competence to undergo β-selection 77, [111] [112] [113] [114] [115] [116] (FIG. 4b) . Cis-regulatory analysis of the TCR and RAG1-RAG2 loci indicates specific sites at which most of these factors can be implicated in direct regulation (reviewed in REF. 2) . Although the increase in the expression of these transcription factors is minimal in the transition from Dn2 to Dn3 stages (FIG. 2b,c) , their functions are most probably modified by the induction of new participants. of particular interest, ETs1 and ETs2 are sharply upregulated at this point (FIG. 2b,c) . ETs1 collaborates with RunX1 in TCR gene expression and might enhance RunX1 activity profoundly 67 . Another ETs factor, sPIB, might contribute to checkpoint arrest 97 . Pu.1 specifically inhibits ETs1, ETs2 and sPIB expression in thymocytes 52 , and so the timing of their induction may be dependent on the downregulation of Pu.1.
As in all the previous stages, notch and E proteins have major roles too. The Dn3 stage is the peak period for expression of target genes of the notch-RBPj-complex and Eproteins, such as Deltex1, Rag1, Hes1 and Ptcra (FIG. 2) . Mouse Dn3a pro-T cells, before β-or γδ-selection, are acutely dependent on notch signalling to maintain viability through phosphoinositide 3-kinase (PI3K) pathway signals and activation of the proto-oncogene Myc [117] [118] [119] . The activity of E2A and HEB is crucial not only for TCR gene rearrangement 62 , but also for the ability to undergo normal β-selection even when a rearranged TCR transgene is supplied 120 . E2A and HEB together are particularly implicated in maintaining proliferative arrest at the Dn3 stage 121 : in part they activate expression of growth inhibitory factors, such as suppressor of cytokine signalling 1 (soCs1) and soCs3 proteins, which uncouple growthfactor receptors such as Il-7R from their signalling pathways; and in part they directly inhibit cell-cycle-activating genes such as Cdk6 (REF. 122 ). This cell-cycle-arresting role of E proteins is important for checkpoint control (FIG. 4b) . When E2A is mutated, not only is TCR gene rearrangement defective, but also the penalty for failure is removed, and cells can proceed abnormally through the β-selection checkpoint 123 . such E2A-deficient unchecked cells are prone to leukaemic transformation. However, note that if E2A and HEB were to exercise this function earlier, they would abort T-cell development, as is seen when these factors are experimentally overexpressed 64 . Finally, there is new evidence that E proteins are also responsible for making the Dn2 to Dn3 stage transition irreversible. Both E2A and HEB together have been conditionally deleted in Dn3 thymocytes, and the loss of these E proteins not only prevents proliferative arrest at the Dn3 stage but also enables Dn3 cells to undergo reverse differentiation to return to a Dn2-cell-like phenotype 121 . A key question now is whether such removal of E-protein activity might also be sufficient to restore expression of the progenitor-cell regulatory factors and broader developmental potentials of earlier states.
Directly or indirectly, the uniqueness of the Dn3 stage may depend on particularly high doses of both notch and E-protein activity. The peak-level expression of notch target genes could reflect the naturally decreased expression of MInT in the Dn3 cells 92 . Alternatively it could reflect the enhanced responsiveness to deltafamily notch ligands through increased expression of the modifier lunatic fringe (Lfng) 124 or the migration into an intrathymic zone 8 (such as the subcapsular region see FIG. 1 ) that presents Dll4, an increasingly potent notch ligand 125 . In parallel, although E protein (E2A and HEBcan) gene expression itself is relatively unchanged throughout development 64 (FIG. 2b) , the accumulation of E protein greatly increases at the Dn3a stage 126 . Reduced sCl and ID2 expression could be responsible, although surprisingly, ID3 expression increases at this stage and might be expected to continue antagonizing E-protein activity 34 (FIG. 2b,c) . The high accumulation of HEBalt in Dn3 cells may contribute, either as a highly stabilizing partner for full-length E proteins or as an ID-interaction decoy 64 . Adjustments in levels of notch and E proteins can apparently compensate for each other 78 . Fetal murine pro-T-cells express surprisingly high levels of ID2 which should inhibit E protein activity, but transcriptional evidence also suggests they experience unusually strong notch activity which may compensate 34 . Commitment depends not only on irreversibility but also on repression, and the main unresolved issue about the Dn2 to Dn3 stage transition is how the non-T-cell factors become silenced in the Dn2 and Dn3 stages. The sweeping downregulation of factors such as Pu.1 and sCl from high stem-cell levels 53 are among the most profound regulatory changes that occur during T-cell specification. However, very little is known yet about T-cell-lineage-promoting repression. notch signalling induces expression of the repressor HEs1 but this factor probably does not repress Pu.1, as it is not required to block myeloid potential or confer T-cell potential in fetal progenitors 23 . It may be more important that RunX1, MYB, and TCF1 and lEF1 factors, all expressed at peak levels in Dn3 cells, also have the capacity to act as repressors, especially in certain isoforms. In this context, the repressor activity of BCl-11B is also of particular interest. The key factors may be defined by their interaction with the co-repressor nCoR1 (nuclear receptor co-repressor 1), which is reportedly essential to prepare cells for β-selection 127 . Cis-regulatory analysis of repression targets Scl and Sfpi1 could 'bait the trap' to identify repressors mediating commitment.
From haematopoiesis to immunology
From β-or γδ-selection onwards, multiple regulatory changes are triggered by TCR signals, but T-cell-lineage identity is completely and stably established. The basic set of T-cell-lineage effector genes continues to be expressed as the cells diverge to αβ T-cell, γδ T-cell and other specialized T-cell lineages (FIG. 2a) , even though quite different combinations of transcription factors are used in γδ T cells and different subsets of αβ T-cell lineages 27, 59, 68, 128 ( FIG. 2b) . Most importantly, neither the thymic microenvironment nor the Dn3-cell transcription factor set are needed to maintain the T-cell identity of the cells. notch signal-dependent transcription becomes dispensable 129 , E-protein activity is at least reduced, and many of the transcription factors that participated in the early T-cell precursor stages decrease or disappear 37, 38 (FIG. 2b) .
This means that the specification mechanisms that turned on T-cell genes probably work in a ratchet-like fashion to make activation of genes such as Cd3g and Cd3e virtually irreversible. one way this could occur is by substituting the roles of the transcription factors that initiate development with different members of the same transcription factor family that are expressed stably in mature cells. For example, the ETs-family transcription factor GABPα can drive expression of Il-7Rα in Pu.1-negative cells through the same cis-element that Pu.1 uses when it is present 130 . Another mechanism is probably the establishment of durable epigenetic changes in the accessibility of T-cell and non-T-cell genes, which could make continuing T-cell gene expression a default, no longer dependent on delicately titrated regulatory balances. such mechanisms are probably essential to explain the completion of the specification process and may be even more important for establishing a strong barrier against reactivation of the non-T-cell regulators that were expressed at earlier stages.
Concluding remarks T-cell specification is a segmented process. The completion of T-cell-lineage commitment is far removed from the initial responses to notch signalling, with distinct steps in between that are sensitive to environmental influence. ongoing requirements for notch and E proteins provide continuities throughout this process, but different sets of notch and E protein target genes are activated at each step. As discussed here, this is because each step is distinguished by changes in other transcription factors and sensitivities to changing cytokines and other signals encountered during migration through the thymus that create a constantly shifting regulatory context. As suggested elsewhere 7 , some of the remarkable developmental stability of T-cell identity after β-selection might be due to the completeness with which the cells finally extinguish expression of the regulators for competing fates. The identity of the critical silencing functions is another remaining mystery. It will now be important to determine the exact mechanisms that control deployment of the notch-RBPj complex, E proteins, and other core-group factors that seem to be present throughout, to activate precisely shifting sets of T-cell-lineage genes at each step.
